These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 27705010)

  • 41. Immediate Effect of Stimulability Assessment on Acoustic, Aerodynamic, and Patient-Perceptual Measures of Voice.
    Gillespie AI; Gartner-Schmidt J
    J Voice; 2016 Jul; 30(4):507.e9-507.e14. PubMed ID: 26233832
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age Estimation and Gender Attribution in Typically Developing Children and Children With Dysarthria.
    Haas E; Ziegler W; Schölderle T
    Am J Speech Lang Pathol; 2024 May; 33(3):1236-1253. PubMed ID: 38416062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prosodic Improvement in Persons with Parkinson Disease Receiving SPEAK OUT!® Voice Therapy.
    Boutsen F; Park E; Dvorak J; Cid C
    Folia Phoniatr Logop; 2018; 70(2):51-58. PubMed ID: 29996139
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Validation of the Acoustic Voice Quality Index in the Japanese Language.
    Hosokawa K; Barsties B; Iwahashi T; Iwahashi M; Kato C; Iwaki S; Sasai H; Miyauchi A; Matsushiro N; Inohara H; Ogawa M; Maryn Y
    J Voice; 2017 Mar; 31(2):260.e1-260.e9. PubMed ID: 27287930
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Variability and Diagnostic Accuracy of Speech Intelligibility Scores in Children.
    Hustad KC; Oakes A; Allison K
    J Speech Lang Hear Res; 2015 Dec; 58(6):1695-707. PubMed ID: 26381119
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The impact of Lee Silverman Voice Treatment (LSVT LOUD®) on voice, communication, and participation: Findings from a prospective, longitudinal study.
    Bryans LA; Palmer AD; Anderson S; Schindler J; Graville DJ
    J Commun Disord; 2021; 89():106031. PubMed ID: 33259945
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dysarthria in Adults With Cerebral Palsy: Clinical Presentation and Impacts on Communication.
    Schölderle T; Staiger A; Lampe R; Strecker K; Ziegler W
    J Speech Lang Hear Res; 2016 Apr; 59(2):216-29. PubMed ID: 27057824
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Articulatory Range of Movement in Individuals With Dysarthria Secondary to Amyotrophic Lateral Sclerosis.
    Lee J; Bell M
    Am J Speech Lang Pathol; 2018 Aug; 27(3):996-1009. PubMed ID: 29800071
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Relationship between kinematics, F2 slope and speech intelligibility in dysarthria due to cerebral palsy.
    Rong P; Loucks T; Kim H; Hasegawa-Johnson M
    Clin Linguist Phon; 2012 Sep; 26(9):806-22. PubMed ID: 22876770
    [TBL] [Abstract][Full Text] [Related]  

  • 50. PD Check-In: The development and trial of a supported self-management program for people with Parkinson's disease following intensive speech intervention.
    Finnimore A; Theodoros D; Rumbach AF
    Int J Lang Commun Disord; 2022 Jan; 57(1):138-151. PubMed ID: 34767290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Implementing two treatment approaches to childhood dysarthria.
    Levy ES
    Int J Speech Lang Pathol; 2014 Aug; 16(4):344-54. PubMed ID: 24673184
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Criterion-related validity of the Test of Children's Speech sentence intelligibility measure for children with cerebral palsy and dysarthria.
    Hodge M; Gotzke CL
    Int J Speech Lang Pathol; 2014 Aug; 16(4):417-26. PubMed ID: 25011401
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurogenic Orofacial Weakness and Speech in Adults With Dysarthria.
    Solomon NP; Makashay MJ; Helou LB; Clark HM
    Am J Speech Lang Pathol; 2017 Aug; 26(3):951-960. PubMed ID: 28763804
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Internally Versus Externally Cued Speech in Parkinson's Disease and Cerebellar Disease.
    Weir-Mayta P; Spencer KA; Eadie TL; Yorkston K; Savaglio S; Woollcott C
    Am J Speech Lang Pathol; 2017 Jun; 26(2S):583-595. PubMed ID: 28654941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Predicting speech intelligibility with a multiple speech subsystems approach in children with cerebral palsy.
    Lee J; Hustad KC; Weismer G
    J Speech Lang Hear Res; 2014 Oct; 57(5):1666-78. PubMed ID: 24824584
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Feasibility and Acceptability of Lee Silverman Voice Treatment in Progressive Ataxias.
    Lowit A; Egan A; Hadjivassiliou M
    Cerebellum; 2020 Oct; 19(5):701-714. PubMed ID: 32588316
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical outcomes of PD Check-In, a model for supported self-managed maintenance of speech in Parkinson's disease: A Phase 1 study.
    Finnimore A; Theodoros D; Rumbach AF
    Int J Lang Commun Disord; 2023 Mar; 58(2):241-255. PubMed ID: 36036751
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Differences between Subjective and Objective Assessment of Speech Deficiency in Parkinson Disease.
    Pawlukowska W; Szylińska A; Kotlęga D; Rotter I; Nowacki P
    J Voice; 2018 Nov; 32(6):715-722. PubMed ID: 29122413
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Vocal tract representation in the recognition of cerebral palsied speech.
    Rudzicz F; Hirst G; van Lieshout P
    J Speech Lang Hear Res; 2012 Aug; 55(4):1190-207. PubMed ID: 22271873
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Single Word Intelligibility of Individuals with Parkinson's Disease in Noise: Pre-Specified Secondary Outcome Variables from a Randomized Control Trial (RCT) Comparing Two Intensive Speech Treatments (LSVT LOUD vs. LSVT ARTIC).
    Schulz G; Halpern A; Spielman J; Ramig L; Panzer I; Sharpley A; Freeman K
    Brain Sci; 2021 Jun; 11(7):. PubMed ID: 34199093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.